Acorda Therapeutics Inc (NASDAQ:ACOR)

31.61
Delayed Data
As of May 26
 -0.40 / -1.25%
Today’s Change
28.26
Today|||52-Week Range
45.45
-22.66%
Year-to-Date

Today’s Trading

Previous close32.01
Today’s open31.85
Day’s range31.32 - 32.23
Volume698,058
Average volume (3 months)655,684
Market cap$1.4B
Dividend yield--
Data as of 4:00pm ET, 05/26/2015

Growth & Valuation

Earnings growth (last year)+7.69%
Earnings growth (this year)-172.63%
Earnings growth (next 5 years)+37.00%
Revenue growth (last year)+19.34%
P/E ratio96.7
Price/Sales4.19
Price/Book2.48

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...-0.31-2.47%
INSMInsmed Inc-0.49-2.17%
RGENRepligen Corp-0.37-0.91%
ZSPHZS Pharma Inc+0.96+1.66%
Data as of 4:00pm ET, 05/26/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$401.5M
Annual profit (last year)$17.7M
Net profit margin4.40%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers